Patient and Public Engagement

Name: Strategies for AAV capsid engineering
Start: 2026-03-26T18:30:00+00:00
End: 2026-03-26T19:15:00+00:00

March 2025
Public & Patient Series – Liver directed lentiviral gene therapy for inherited cholestatic disorders

March 12, 2025 @ 6:30 pm - 7:30 pm

Virtual Event

Approximately 1 in 2500 neonates develop cholestatic jaundice, often due to rare genetic disorders with no cure and severe morbidity. This talk will explore how innovative lentiviral gene therapies could transform treatment, using ARC syndrome as a case study. We will highlight key breakthroughs in optimizing gene delivery and ensuring vector safety— crucial steps toward…

Free
August 2025
BSGCT PPE Talk – The IKEA Model: Why your cells are basically a DIY furniture manufacturer, and how we can use that to treat genetic disease

August 6, 2025 @ 6:30 pm - 7:30 pm

Virtual Only. REGISTRATION IS FREE - Sign up here to receive the joining link. BSGCT Invites you to our next Public and Patient Engagement (PPE) talk. Join Dr. Carina Graham, Research Associate, St John's Institute of Dermatology, Guy's Hospital. Register here
December 2025
BSGCT PPE Talk – Going Viral: How To Tame And Train A Virus Into A Cancer Fighting Therapy

December 10, 2025 @ 6:30 pm - 7:30 pm

Virtual Only. REGISTRATION IS FREE - Sign up here to receive the joining link. BSGCT Invites you to our next Public and Patient Engagement (PPE) talk. Join Dr Charley Lovatt-Travers is a research associate working with Professor Alan Parker in the Viral ImmunoTherapies and Advanced therapeutics Laboratory (VITAL) at the Division of Cancer and Genetics,…
March 2026
School & Public Engagement Day

March 13 @ 10:00 am - 4:00 pm

School students (Years 11-13), patients and the public are invited to join us for this FREE interactive event which introduces and explores gene and cell therapy. This is a fantastic opportunity to: Meet leading scientists Discover cutting-edge research Hear from patients and those affected by relevant diseases Explore career options Discuss the ethical implications and…
Strategies for AAV capsid engineering

March 26 @ 6:30 pm - 7:15 pm

AAV is a promising delivery vehicle for gene therapies with potential to be engineered for improved targeting, higher potency and lower immunogenicity. However, challenges also remain to improve their manufacturing and stability to achieve lower costs and ease of formulation and delivery. Protein engineering provides a viable route to creating platform vectors ready-made for low cost…

Events Calendar

Patient and Public Engagement

March 2025

Public & Patient Series – Liver directed lentiviral gene therapy for inherited cholestatic disorders

August 2025

BSGCT PPE Talk – The IKEA Model: Why your cells are basically a DIY furniture manufacturer, and how we can use that to treat genetic disease

December 2025

BSGCT PPE Talk – Going Viral: How To Tame And Train A Virus Into A Cancer Fighting Therapy

March 2026

School & Public Engagement Day

Strategies for AAV capsid engineering

Quick Links